C.I.R. Dental School
Torino, 10126, Italy
NCT Number: NCT07501754
Epithelialized gingival graft (EGG) harvesting from the palate is associated with postoperative morbidity, including pain and bleeding, due to healing by secondary intention. The effectiveness of palatal stents in reducing donor-site morbidity, particularly in suture-free techniques, remains unclear.
This randomized controlled clinical trial evaluates the effect of a custom-made acrylic palatal stent (APS) compared with no stent on postoperative outcomes following EGG harvesting.
The primary outcome is postoperative pain assessed using a visual analog scale (VAS). Secondary outcomes include other patient-reported measures, clinician-reported healing, and exploratory assessments of tissue healing.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Torino, 10126, Italy
Epithelialized gingival graft (EGG) harvesting is widely used in periodontal plastic surgery but is associated with postoperative discomfort at the palatal donor site. Healing occurs by secondary intention and may result in pain, bleeding, and delayed recovery.
Palatal stents have been proposed as a mechanical approach to protect the wound and reduce morbidity; however, evidence supporting their effectiveness, especially in suture-free techniques, is limited.
This randomized controlled, assessor-blind, parallel-arm clinical trial aims to evaluate the effect of a custom-made acrylic palatal stent (APS) on postoperative morbidity following EGG harvesting. Patients were randomly assigned to receive APS or no stent after surgery.
The primary outcome is postoperative pain. Secondary outcomes include patient-reported measures, clinical healing parameters, and exploratory assessments of tissue healing.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A custom-made acrylic palatal stent (APS) will be fabricated prior to surgery based on an impression of the maxillary arch. The device will be thermoformed, trimmed, polished, and adjusted for proper fit and retention.
Following epithelialized gingival graft (EGG) harvesting, the APS will be positioned over the palatal donor site to provide mechanical protection and stabilization of the blood clot. The stent will be worn continuously during the early healing phase according to the study protocol.
Following epithelialized gingival graft (EGG) harvesting, no protective device will be applied to the palatal donor site. Hemostasis will be achieved through local anesthesia only, without the use of sutures, pressure, or additional hemostatic agents. Healing will occur by secondary intention
Time frame: 7 days after surgery
Postoperative pain assessed using a 100-mm visual analog scale (VAS), where 0 indicates no pain and 100 indicates worst imaginable pain. Patients will record pain daily using standardized questionnaires
Time frame: Daily from Day 1 to Day 7, Day 14, 21, 28
Patient-reported bleeding at the palatal donor site assessed using a 100-mm VAS
Time frame: Daily from Day 1 to Day 7, day 14, 21, 28
Patient-reported swelling assessed using a 100-mm VAS.
Time frame: 7 days after surgery
Total intake of ibuprofen (mg) recorded by patients during the postoperative period.
Time frame: Baseline, 7 days, 14 days, 21 days, 28 days
Oral health-related quality of life assessed using the OHIP-14 questionnaire
Time frame: 28 days after surgery
Patient willingness to undergo a similar procedure in the future (yes/no)
Time frame: 7 and 14 days after surgery
Wound epithelialization assessed using hydrogen peroxide (H₂O₂) test and classified as none, partial, or complete.
Time frame: 7, 14 days
Healing assessed from standardized photographs evaluating color match, tissue contour, and scar appearance using visual analog scales.
Time frame: Baseline, 7, 14, 21, 28 days after surgery
Quantitative assessment of palatal tissue healing using OCT, including measurements of epithelial layer, keratin layer, and lamina propria thickness.
Time frame: 4 days post surgery
Levels of inflammatory and healing-related biomarkers (e.g., IL-1β, IL-6, TGF-β1, VEGF-A) measured from palatal wound exudate using multiplex assay.
Time frame: up to 28 days
Incidence of complications including infection, delayed healing, excessive bleeding, or other adverse events.
University of Turin, Italy
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04401007
Agnosia, Nervous System Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT07736118
Agnosia, Behavior
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT06811701
Agnosia, Craniotomy Surgery
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07722221
Agnosia, Dental Anxiety
Latakia, Syria
View Trial Details